U.S. Markets closed
  • S&P Futures

    3,274.00
    -28.25 (-0.86%)
     
  • Dow Futures

    26,390.00
    -167.00 (-0.63%)
     
  • Nasdaq Futures

    11,197.50
    -145.25 (-1.28%)
     
  • Russell 2000 Futures

    1,548.90
    -9.50 (-0.61%)
     
  • Crude Oil

    36.40
    +0.23 (+0.64%)
     
  • Gold

    1,871.80
    +3.80 (+0.20%)
     
  • Silver

    23.51
    +0.15 (+0.64%)
     
  • EUR/USD

    1.1688
    +0.0010 (+0.0818%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2936
    +0.0013 (+0.0970%)
     
  • USD/JPY

    104.4690
    -0.1410 (-0.1348%)
     
  • BTC-USD

    13,482.71
    +52.04 (+0.39%)
     
  • CMC Crypto 200

    265.74
    +23.06 (+9.50%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,152.24
    -179.70 (-0.77%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BIDU, UPLCQ and NXTC

·3 mins read

NEW YORK, NY / ACCESSWIRE / October 1, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Baidu, Inc. (NASDAQ:BIDU)
Class Period: April 8, 2016 - August 13, 2020
Lead Plaintiff Deadline: October 19, 2020

The complaint alleges that throughout the class period Baidu, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Baidu misrepresented the financial and business condition of iQIYI; (2) iQIYI had inadequate controls; and (3) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in BIDU: http://www.kleinstocklaw.com/pslra-1/baidu-inc-loss-submission-form-2?id=9743&from=1

Ultra Petroleum Corp. (OTC PINK:UPLCQ)
Class Period: April 3, 2017 - August 8, 2019
Lead Plaintiff Deadline: November 2, 2020

Throughout the class period, Ultra Petroleum Corp. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) Ultra's proved reserves were materially overstated and, therefore, worth hundreds of millions of dollars less than represented; (b) Ultra's proved undeveloped reserves were of de minimis value because they contained low quality deposits that lacked a commercially viable path to development; (c) Ultra was unable to meet the production and development estimates provided to investors and such estimates lacked a reasonable basis; (d) Ultra was unable to withstand even a modest downturn in the price of natural gas because, inter alia, Ultra's business had less financial and production flexibility than claimed; and (e) Ultra did not have the technical or financial capabilities or available asset base to sustainably grow its oil and natural gas production by any meaningful amount.

Learn about your recoverable losses in UPLCQ: http://www.kleinstocklaw.com/pslra-1/ultra-petroleum-corp-loss-submission-form?id=9743&from=1

Nextcure, Inc. (NASDAQ:NXTC)
The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.
Lead Plaintiff Deadline: November 20, 2020

Throughout the class period defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

Learn about your recoverable losses in NXTC: http://www.kleinstocklaw.com/pslra-1/nextcure-inc-loss-submission-form?id=9743&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/608805/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-BIDU-UPLCQ-and-NXTC